Evolent Health Files 8-K
Ticker: EVH · Form: 8-K · Filed: Aug 18, 2025 · CIK: 1628908
Sentiment: neutral
Topics: regulatory-filing, 8-K
Related Tickers: EVLT
TL;DR
EVLT filed a standard 8-K, no major news.
AI Summary
Evolent Health, Inc. filed an 8-K on August 18, 2025, reporting other events and financial statements. The filing does not contain specific details on new events, acquisitions, or financial performance beyond the standard reporting requirements.
Why It Matters
This filing indicates Evolent Health is meeting its regulatory reporting obligations. It does not appear to contain material new information for investors at this time.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report and does not disclose any new risks or material adverse events.
Key Players & Entities
- Evolent Health, Inc. (company) — Registrant
- August 18, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of incorporation
- 001-37415 (identifier) — Commission file number
- 32-0454912 (identifier) — I.R.S. Employer Identification No.
- 1812 N. Moore Street , Suite 1705 (address) — Principal executive offices
- Arlington, Virginia (location) — Principal executive offices location
- 22209 (zip_code) — Principal executive offices zip code
- (571) 389-6000 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing by Evolent Health, Inc.?
The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of August 18, 2025.
When was this 8-K report filed by Evolent Health, Inc.?
This 8-K report was filed on August 18, 2025.
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant is Evolent Health, Inc.
Where are Evolent Health, Inc.'s principal executive offices located?
Evolent Health, Inc.'s principal executive offices are located at 1812 N. Moore Street, Suite 1705, Arlington, Virginia, 22209.
Does this filing indicate any specific new material events or financial changes?
This filing is a standard 8-K reporting 'Other Events' and 'Financial Statements and Exhibits' and does not specify any new material events or detailed financial changes within the provided text.
Filing Stats: 838 words · 3 min read · ~3 pages · Grade level 10.5 · Accepted 2025-08-18 16:18:09
Key Financial Figures
- $0.01 — tock of Evolent Health, Inc., par value $0.01 per share EVH New York Stock Exchan
- $140.0 million — lease announcing the intention to offer $140.0 million aggregate principal amount of its conve
- $20.0 million — option to purchase up to an additional $20.0 million aggregate principal amount of notes. A
- $100.0 million — nce. The Company intends to use up to $100.0 million of the net proceeds from the offering t
- $40.0 million — 25 (the "2025 Notes") and approximately $40.0 million of the net proceeds of the offering to
- $0 — common stock of the Company, par value $0.01, issuable upon conversion of the not
Filing Documents
- d24921d8k.htm (8-K) — 27KB
- d24921dex991.htm (EX-99.1) — 11KB
- g24921g0816030137168.jpg (GRAPHIC) — 6KB
- 0001193125-25-182692.txt ( ) — 164KB
- evh-20250818.xsd (EX-101.SCH) — 3KB
- evh-20250818_lab.xml (EX-101.LAB) — 18KB
- evh-20250818_pre.xml (EX-101.PRE) — 11KB
- d24921d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release of Evolent Health, Inc. dated August 18, 2025 104 The cover page from this Current Report on Form 8-K, formatted as Inline XBRL SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. EVOLENT HEALTH, INC. By: /s/ Jonathan D. Weinberg Jonathan D. Weinberg General Counsel and Secretary Dated: August 18, 2025